亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

隨州市紅旗化工有限公司  

醫(yī)藥原料醫(yī)藥中間體原料藥

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:閆先生
  • 電話:0722-3257386
  • 傳真:0722-3257381
  • QQ:1374834438
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 乙胺嘧啶 CAS號: 58-14-0
乙胺嘧啶 CAS號: 58-14-0
單價 面議對比
詢價 暫無
發(fā)貨 湖北隨州市付款后3天內(nèi)
型號 58-14-0
過期 長期有效
更新 2020-06-18 10:08
 
詳細信息


乙胺嘧啶
CAS號: 58-14-0
中文別名: 息瘧定; 達拉匹林; 2,4-二氨基-6-乙基-5-對氯苯基嘧啶; 6-乙基-5-(4-氯苯基)-2,4-嘧啶二胺
英文名稱: Pyrimethamine
英文別名: 2,4-diamino-5-(p-chlorophenyl)-6-ethylpyrimidine; 5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diyldiamine
EINECS號: 200-364-2
分子式: C12H13ClN4
分子量: 248.71
 熔點 233-234°C
水溶性 <0.01 g/100 mL at 21°C
標準:BP2002,USP27
含量:99.0-101.0%
性狀:為白色結(jié)晶性粉末,無臭、無味
用途 :抗瘧藥,用于瘧疾的病因性預防及抗復發(fā)治療
包裝規(guī)格:25公斤桶

©2025 隨州市紅旗化工有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:31447  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |